Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017176137> ?p ?o ?g. }
- W2017176137 endingPage "2162" @default.
- W2017176137 startingPage "2156" @default.
- W2017176137 abstract "Colorectal neoplasia causes bleeding, enabling detection using Faecal Occult Blood tests (FOBt). The National Health Service (NHS) Bowel Cancer Screening Programme (BCSP) guaiac-based FOBt (gFOBt) kits contain six sample windows (or 'spots') and each kit returns either a positive, unclear or negative result. Test kits with five or six positive windows are termed 'abnormal' and the subject is referred for further investigation, usually colonoscopy. If 1-4 windows are positive, the result is initially 'unclear' and up to two further kits are submitted, further positivity leads to colonoscopy ('weak positive'). If no further blood is detected, the test is deemed 'normal' and subjects are tested again in 2 years' time. We studied the association between spot positivity % (SP%) and neoplasia.Subjects in the Southern Hub completing the first of two consecutive episodes between April 2009 and March 2011 were studied. Each episode included up to three kits and a maximum of 18 windows (spots). For each positivity combination, the percentage of positive spots out of the total number of spots completed by an individual in a single-screening episode was derived and named 'SP%'. Fifty-five combinations of SP can occur if the position of positive/negative spots on the same test card is ignored.The proportion of individuals for whom neoplasia was identified in Episode 2 was derived for each of the 55 spot combinations. In addition, the Episode 1 spot pattern was analysed for subjects with cancer detected in Episode 2.During Episode 2, 284,261 subjects completed gFOBT screening and colonoscopies were performed on 3891 (1.4%) subjects. At colonoscopy, cancer was detected in 7.4% (n=286) and a further 39.8% (n=1550) had adenomas. Cancer was detected in 21.3% of subjects with an abnormal first kit (five or six positive spots) and in 5.9% of those with a weak positive test result.The proportion of cancers detected was positively correlated with SP%, with an R(2) correlation (linear) of 0.89. As the SP% increased from 11 to 100%, so the colorectal cancer (CRC) detection rate increased from 4 to 25%. At the lower SP%s, from 11to 25%, the CRC risk was relatively static at ~4%. Above an SP% of 25%, every 10-percentage points increase in the SP%, was associated with an increase in cancer detection of 2.5%.This study demonstrated a strong correlation between SP% and cancer detection within the NHS BCSP. At the population level, subjects' cancer risk ranged from 4 to 25% and correlated with the gFOBt spot pattern.Some subjects with an SP% of 11% proceed to colonoscopy, whereas others with an SP% of 22% do not. Colonoscopy on patients with four positive spots in kit 1 (SP% 22%) would, we estimate, detect cancer in ~4% of cases and increase overall colonoscopy volume by 6%. This study also demonstrated how screening programme data could be used to guide its ongoing implementation and inform other programmes." @default.
- W2017176137 created "2016-06-24" @default.
- W2017176137 creator A5007856380 @default.
- W2017176137 creator A5015066732 @default.
- W2017176137 creator A5017933355 @default.
- W2017176137 creator A5036111873 @default.
- W2017176137 creator A5057028233 @default.
- W2017176137 creator A5071544771 @default.
- W2017176137 creator A5073438373 @default.
- W2017176137 creator A5077655879 @default.
- W2017176137 creator A5082354627 @default.
- W2017176137 date "2014-09-16" @default.
- W2017176137 modified "2023-10-09" @default.
- W2017176137 title "Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm" @default.
- W2017176137 cites W1521660172 @default.
- W2017176137 cites W1572551720 @default.
- W2017176137 cites W1734611882 @default.
- W2017176137 cites W1965538008 @default.
- W2017176137 cites W1969836394 @default.
- W2017176137 cites W1976111569 @default.
- W2017176137 cites W1980204665 @default.
- W2017176137 cites W1980399237 @default.
- W2017176137 cites W2009460002 @default.
- W2017176137 cites W2022972284 @default.
- W2017176137 cites W2033507790 @default.
- W2017176137 cites W2042986451 @default.
- W2017176137 cites W2051952521 @default.
- W2017176137 cites W2066795305 @default.
- W2017176137 cites W2099581302 @default.
- W2017176137 cites W2101298763 @default.
- W2017176137 cites W2123407551 @default.
- W2017176137 cites W2131098741 @default.
- W2017176137 cites W2136854879 @default.
- W2017176137 cites W2149864556 @default.
- W2017176137 cites W2152823722 @default.
- W2017176137 cites W2161920747 @default.
- W2017176137 cites W2168828567 @default.
- W2017176137 cites W92879319 @default.
- W2017176137 doi "https://doi.org/10.1038/bjc.2014.480" @default.
- W2017176137 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4260024" @default.
- W2017176137 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25225905" @default.
- W2017176137 hasPublicationYear "2014" @default.
- W2017176137 type Work @default.
- W2017176137 sameAs 2017176137 @default.
- W2017176137 citedByCount "9" @default.
- W2017176137 countsByYear W20171761372015 @default.
- W2017176137 countsByYear W20171761372016 @default.
- W2017176137 countsByYear W20171761372017 @default.
- W2017176137 countsByYear W20171761372018 @default.
- W2017176137 countsByYear W20171761372021 @default.
- W2017176137 countsByYear W20171761372022 @default.
- W2017176137 countsByYear W20171761372023 @default.
- W2017176137 crossrefType "journal-article" @default.
- W2017176137 hasAuthorship W2017176137A5007856380 @default.
- W2017176137 hasAuthorship W2017176137A5015066732 @default.
- W2017176137 hasAuthorship W2017176137A5017933355 @default.
- W2017176137 hasAuthorship W2017176137A5036111873 @default.
- W2017176137 hasAuthorship W2017176137A5057028233 @default.
- W2017176137 hasAuthorship W2017176137A5071544771 @default.
- W2017176137 hasAuthorship W2017176137A5073438373 @default.
- W2017176137 hasAuthorship W2017176137A5077655879 @default.
- W2017176137 hasAuthorship W2017176137A5082354627 @default.
- W2017176137 hasBestOaLocation W20171761371 @default.
- W2017176137 hasConcept C121608353 @default.
- W2017176137 hasConcept C126322002 @default.
- W2017176137 hasConcept C141071460 @default.
- W2017176137 hasConcept C142724271 @default.
- W2017176137 hasConcept C204787440 @default.
- W2017176137 hasConcept C2776463041 @default.
- W2017176137 hasConcept C2778435480 @default.
- W2017176137 hasConcept C2779158730 @default.
- W2017176137 hasConcept C2781255879 @default.
- W2017176137 hasConcept C520017518 @default.
- W2017176137 hasConcept C526805850 @default.
- W2017176137 hasConcept C71924100 @default.
- W2017176137 hasConcept C90924648 @default.
- W2017176137 hasConceptScore W2017176137C121608353 @default.
- W2017176137 hasConceptScore W2017176137C126322002 @default.
- W2017176137 hasConceptScore W2017176137C141071460 @default.
- W2017176137 hasConceptScore W2017176137C142724271 @default.
- W2017176137 hasConceptScore W2017176137C204787440 @default.
- W2017176137 hasConceptScore W2017176137C2776463041 @default.
- W2017176137 hasConceptScore W2017176137C2778435480 @default.
- W2017176137 hasConceptScore W2017176137C2779158730 @default.
- W2017176137 hasConceptScore W2017176137C2781255879 @default.
- W2017176137 hasConceptScore W2017176137C520017518 @default.
- W2017176137 hasConceptScore W2017176137C526805850 @default.
- W2017176137 hasConceptScore W2017176137C71924100 @default.
- W2017176137 hasConceptScore W2017176137C90924648 @default.
- W2017176137 hasIssue "11" @default.
- W2017176137 hasLocation W20171761371 @default.
- W2017176137 hasLocation W20171761372 @default.
- W2017176137 hasLocation W20171761373 @default.
- W2017176137 hasLocation W20171761374 @default.
- W2017176137 hasOpenAccess W2017176137 @default.
- W2017176137 hasPrimaryLocation W20171761371 @default.
- W2017176137 hasRelatedWork W1549347960 @default.
- W2017176137 hasRelatedWork W1800789698 @default.